It was reported that this implantable cardioverter defibrillator (icd) delivered therapy due to an atrial fibrillation (af) event with rapid ventricular response.Boston scientific technical services (ts) was consulted and upon review, it was noted that the atrial channel showed af with a variable ventricular rhythm to begin with.The ventricular rhythm became fast and regular enough to fall into the vt zone where it remained sustained long enough for anti-tachycardia pacing (atp) to be delivered.Four bursts of atp were delivered, all of which were unsuccessful.The last burst appears to have accelerated the rhythm into the vf zone where a single 41j shock converted both arrhythmias.No additional adverse patient effects were reported.At this time, this device remains in service.
|